We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$193B
AUM Growth
+$9.98B
Cap. Flow
+$5.76B
Cap. Flow %
2.98%
Top 10 Hldgs %
13.3%
Holding
8,497
New
756
Increased
3,610
Reduced
2,944
Closed
742

Sector Composition

Rank Sector Weight
1 Financials 7.75%
2 Healthcare 6.75%
3 Technology 6.26%
4 Industrials 5.06%
5 Consumer Discretionary 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAMP icon
6851
LiveRamp
RAMP
$2.3B
$8K ﹤0.01%
314
-6,705
-96% -$182K
SNDX icon
6852
Syndax Pharmaceuticals
SNDX
$1.73B
$8K ﹤0.01%
541
-932
-63% -$10.7K
UAVS icon
6853
AgEagle Aerial Systems
UAVS
$41.9M
$8K ﹤0.01%
+1
New +$8.63K
UONEK icon
6854
Urban One Class D
UONEK
$22.1M
$8K ﹤0.01%
341
+74
+28% +$1.85K
UPV icon
6855
ProShares Ultra FTSE Europe
UPV
$17.1M
$8K ﹤0.01%
165
-325
-66% -$15.9K
UTSI icon
6856
UTStarcom
UTSI
$23.3M
$8K ﹤0.01%
875
+769
+725% +$6.59K
VLU icon
6857
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$749M
$8K ﹤0.01%
+86
New +$7.87K
XENE icon
6858
Xenon Pharmaceuticals
XENE
$6.2B
$8K ﹤0.01%
+2,530
New +$9.89K
XOMA
6859
DELISTED
Xoma
XOMA
$8K ﹤0.01%
1,081
-1,011
-48% -$6.73K
ZDGE icon
6860
Zedge
ZDGE
$38.8M
$8K ﹤0.01%
3,688
-437
-11% -$1.23K
TRAW icon
6861
Traws Pharma
TRAW
$6.72M
$8K ﹤0.01%
+1
New +$12.4K
PHLT
6862
DELISTED
Performant Healthcare Inc
PHLT
$8K ﹤0.01%
+3,694
New +$8.33K
SNAX
6863
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$8K ﹤0.01%
53
-7
-12% -$1.06K
PRMW
6864
DELISTED
Primo Water Corporation
PRMW
$8K ﹤0.01%
560
-40
-7% -$533
BFIT
6865
DELISTED
Global X Funds Global X Health & Wellness ETF
BFIT
$8K ﹤0.01%
473
+278
+143% +$4.37K
IBML
6866
DELISTED
iShares iBonds Dec 2023 Term Muni Bond ETF
IBML
$8K ﹤0.01%
+303
New +$7.69K
VRAY
6867
DELISTED
ViewRay, Inc.
VRAY
$8K ﹤0.01%
1,275
-21,204
-94% -$142K
AGRX
6868
DELISTED
Agile Therapeutics
AGRX
$8K ﹤0.01%
+1
New +$6.92K
WIL
6869
DELISTED
iPath Women in Leadership ETN
WIL
$8K ﹤0.01%
+131
New +$7.99K
ESXB
6870
DELISTED
Community Bankers Trust Corporation
ESXB
$8K ﹤0.01%
910
-2,238
-71% -$17.9K
MDLY
6871
DELISTED
Medley Management Inc
MDLY
$8K ﹤0.01%
118
-119
-50% -$8.1K
MLPY
6872
DELISTED
Morgan Stanley Cushing MLP High Income Index ETN
MLPY
$8K ﹤0.01%
1,082
+803
+288% +$6.08K
SMRT
6873
DELISTED
Stein Mart Inc
SMRT
$8K ﹤0.01%
5,001
-25,808
-84% -$51K
SAEX
6874
DELISTED
SAExploration Holdings, Inc.
SAEX
$8K ﹤0.01%
+125
New +$11.1K
IDXG
6875
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$8K ﹤0.01%
867
+746
+617% +$14.6K

Similar funds

UBS Group's Q2 2017 Portfolio in Review

As of Q2 2017, UBS Group held 8,497 positions worth $193B, up 5.4% from $183B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2017 filing shows 756 new, 3,610 increased, 2,944 reduced and 742 closed positions. Its largest new stake was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.

By sector, the portfolio is most concentrated in Financials at 7.7% of assets, up from 7.4% a quarter earlier, followed by Healthcare and Technology.

  • UBS Group's largest Q2 2017 buy was Ultra Petroleum Corp. Common Stock: 3,128,785 shares worth $33.9M.
  • UBS Group added most to Monsanto Co in Q2 2017, an estimated $622M increase.
  • UBS Group's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
  • UBS Group fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $383M.
  • UBS Group's ten largest holdings make up 13% of its $193B portfolio in Q2 2017.
  • UBS Group opened 756 new positions and closed 742 in Q2 2017.
  • UBS Group's portfolio value rose 5.4% quarter-over-quarter to $193B.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.